Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by the presence of senile plaques caused by extracellular amyloid beta (Aβ) aggregation, neurofibrillary tangles triggered by abnormal accumulation of hyperphosphorylated tau protein, and neuronal loss in the cerebral cortex and hippocampus, as well as mitochondrial dysfunction (Bhute et al., 2020). Clinical manifestations of AD are spatial disorientation, language problems, cognitive dysfunction, memory loss, and disturbances in personality (Terracciano, An, Sutin, Thambisetty, & Resnick, 2017). AD as the most common dementia, is thought to be caused by multiple genetic, epigenetic, and environmental factors (Najm et al., 2020). With the aging of the world population and the lack of effective treatment of AD, the morbidity and mortality rates of AD are increasing year by year, and it is estimated that the number of AD patients worldwide will increase to more than 152 million by 2050 (Breijyeh & Karaman, 2020). The escalating prevalence of AD places a huge social and economic burden on modern families and society in recent years (Dong et al., 2020).
Although the pathogenesis of AD remains largely unclear, the amyloid cascade hypothesis that postulates the abnormal aggregation and accumulation of the Aβ as the primary driving-force in AD pathogenesis (Garcia-Leon et al., 2020). The Aβ is an intrinsically disordered protein fragment formed by the action of the β-secretase and γ-secretase on the amyloid precursor protein (APP) (Ellison & Macklin, 2016). Aβ readily self-assembles into amyloid fibrils, which are the major components of the amyloid plaques that represent molecular hallmark of AD (Quartey et al., 2021). Aβ1−40 and Aβ1−42 are the two most abundant forms of Aβ in the brain (Yu et al., 2021). Moreover, Aβ1−42 readily forms aggregates and has higher neurotoxicity than Aβ1−40 (Zhang et al., 2021). The evidence indicates that Aβ oligomers perturb the integrity of membrane lipid bilayers, increase ion permeability, cause calcium influx and consequently affect synaptic transmission and neuronal viability (Tao et al., 2020). Therefore, the inhibition of Aβ production or reducing its aggregation and deposition rate is critical for the pathogenesis of AD.
It has been reported that oxidative stress is involved in the pathogenesis of AD, and reactive oxygen species (ROS) accelerate the development of AD (Tönnies & Trushina, 2017). Oxidative stress refers to an imbalance between ROS production and antioxidant defenses (Zhao et al., 2019). Excessive levels of ROS enhance cellular oxidative stress, which causes lipid peroxidation, protein denaturation, and DNA damage, leading to apoptotic or necroptotic cell death (Zhou et al., 2018). Moreover, oxidative stress has been reported to upregulate the transcription and expression of β-secretase, which is the key enzyme on APP to initiate the Aβ production (Picón-Pagès et al., 2020). In turn, the soluble Aβ oligomers induced ROS, leading to widespread synaptic impairment and neuronal loss in hippocampal neuronal cells (Ganguly, Chakrabarti, Chatterjee, & Saso, 2017). Malondialdehyde (MDA), superoxide dismutase (SOD) and catalase (CAT) are important oxidative stress indicators. Oxidative stress can be recognized by decreased activity of the endogenous antioxidant enzymes such as SOD and CAT, and increased malondialdehyde (MDA) due to lipid peroxidation (Bhattamisra, Yap, Rao, & Choudhury, 2019).
Current treatment options for AD are still limited to acetylcholinesterase inhibitors, receptor antagonists or other supportive methods that can temporarily alleviate symptoms but cannot stop or reverse the progression of AD (Dong, Li, Cheng, & Hou, 2019). Therefore, searching for novel bioactive ingredients for the treatment of Aβ production and accumulation from natural plants has been the subject of research towards the optimal treatment for AD (Kim, Sohn, Kim, Na, & Jeong, 2020). Unlike the chemical drugs, natural polysaccharides, especially plant polysaccharides, have a broad development prospect due to their good biocompatibility, biodegradability, non-toxicity, low cost, and abundance (El-Hawary et al., 2020). Many natural polysaccharides derived from plants possess proven biological properties, including anti-oxidation (Tang et al., 2020), anti-inflammation (Guo et al., 2018), anti-tumor activities (Yang, Guo, Zhang, & Wu, 2007), and improvement of cognitive functions (Zhou et al., 2020). The resource utilization rate of durian is low, and the edible pulp only accounts for one-third of the whole. Most studies on durian seeds remain at the level of nutritional characteristics and application of seed gum (Mirhosseini & Amid, 2013). There are few reports on the active substances in durian seeds (Liu et al., 2013), and even the active polysaccharides in durian seeds have not been reported. In addition, compared with natural plant polysaccharides, low molecular weight plant polysaccharides have better utilization (Liu, Tang, Song, & Ge, 2021).
In this study, enzymatic hydrolysis was used to extract polysaccharides from durian seeds, plasma treatment was employed to effectively degrade the crude polysaccharide of durian seeds. The DPPH radical scavenge capacity and anti-Aβ aggregation activity of polysaccharides from durian seeds were evaluated in vitro. Gel filtration chromatography was performed to obtain the target polysaccharide DSPP-1. The physicochemical properties and chemical structure of DSPP-1 were comprehensively investigated, and the anti-AD activity of DSPP-1 in vivo was evaluated in transgenic C. elegans CL4176 model. Hopefully, this study will provide sufficient experimental evidence of anti-AD activity and potential for further development and utilization of durian seed polysaccharides.